Overview
Interacts with Toll-like receptors (TLR2 and TLR9) on immune cells to activate innate immunity in respiratory epithelium.
Proposed mechanism
Thymosin alpha-1 enhances cell-mediated immunity by promoting T-cell differentiation and modulating cytokine production in lung tissue.
What the evidence supports
Human data exists but the trials are small, short-term, or not yet replicated.
Graded Human-limited
Human data that exists but is thin: open-label work, single-arm studies, small cohorts, or observational follow-up without randomisation.
Key citations
Representative primary sources, including results that did not favour the compound.
- [1]
Thymosin alpha-1 in respiratory infections
· DOI:10.1016/j.phrs.2020.104669 · 2020
- [2]
COVID-19 and TA-1
· DOI:10.1080/22221751.2020.1787109 · 2020
- [3]
Thymosin alpha-1 in respiratory infections (2020)
· · 0
- [4]
COVID-19 and TA-1 (2020)
· · 0
Citation records in this build are illustrative placeholders for the design.
Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.